Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Recurrent or Inoperable Meningioma
NCT00589784Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2007
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in meningioma, hemangiopericytoma (HPC), hemangioblastoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
meningiomahemangiopericytoma (HPC)hemangioblastoma
Beyond the preview
Go deeper on NCT00589784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589784.